Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - Ampio Pharmaceuticals, Inc. | Financial_Report.xls |
10-Q - FORM 10-Q - Ampio Pharmaceuticals, Inc. | d227339d10q.htm |
EX-31.2 - SECTION 302 CFO CERTIFICATION - Ampio Pharmaceuticals, Inc. | d227339dex312.htm |
EX-31.1 - SECTION 302 CEO CERTIFICATION - Ampio Pharmaceuticals, Inc. | d227339dex311.htm |
Exhibit 32.1
AMPIO PHARMACEUTICALS, INC. AND SUBSIDIARIES
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the filing of the quarterly report on Form 10-Q for the quarter ended September 30, 2011 (the Report) by Ampio Pharmaceuticals, Inc. (the Company), each of the undersigned hereby certifies that:
1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and |
2. | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: November 1, 2011 | /S/ DONALD B. WINGERTER, JR. | |
Donald B. Wingerter, Jr. Chief Executive Officer | ||
Dated: November 1, 2011 | /s/ Mark D. McGregor | |
Mark D. McGregor Chief Financial Officer |